Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding

R Bouillon1, D Z Xiang, R Convents

  • 1Laboratorium voor Experimentele Geneeskunde en Endocrinologie (LEGENDO), Onderwijs en Navorsing, Leuven, Belgium.

The Journal of Steroid Biochemistry and Molecular Biology
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus statement from 2<sup>nd</sup> International Conference on Controversies in Vitamin D.

Reviews in endocrine & metabolic disorders·2020
Same author

Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Vitamin D and cardiovascular disorders.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Sunscreen photoprotection and vitamin D status.

The British journal of dermatology·2019
Same author

Is calcifediol better than cholecalciferol for vitamin D supplementation?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

How much vitamin D is needed for healthy bones?

Journal of internal medicine·2017

Free fatty acids, particularly unsaturated ones, significantly impact vitamin D binding protein (DBP) affinity for vitamin D metabolites. This suggests altered vitamin D metabolite bioavailability in vivo.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Nutritional Science

Background:

  • Vitamin D-binding protein (DBP) is crucial for transporting vitamin D metabolites in serum.
  • The binding affinity of DBP influences the bioavailability of active vitamin D forms.
  • Factors affecting DBP binding, such as free fatty acids (FFA), are not fully understood.

Purpose of the Study:

  • To investigate the effect of various substances, including free fatty acids, on the binding affinity of human DBP.
  • To determine how different types of fatty acids (saturated vs. unsaturated) influence DBP's interaction with vitamin D metabolites.

Main Methods:

  • Purified human vitamin D-binding protein (DBP) was used.
  • Binding affinity assays were performed for 25-hydroxyvitamin D3 (25-OHD3) and 1 alpha,25-dihydroxyvitamin D3 [1,25-(OH)2D3] in the presence of FFA, cholesterol, and drugs.

Related Experiment Videos

  • Radioactive tracers ([3H]25-OHD3) were employed to quantify binding.

    • Main Results:

    • Mono- and polyunsaturated fatty acids markedly decreased the binding affinity of DBP for both 25-OHD3 and 1,25-(OH)2D3.
    • Saturated fatty acids, cholesterol, retinol, retinoic acid, and prostaglandins did not significantly affect DBP binding affinity.
    • Physiological concentrations of certain FFAs (arachidonic, oleic acid) significantly reduced 1,25-(OH)2D3 binding, suggesting altered bioavailability.

    Conclusions:

    • Unsaturated fatty acids, but not saturated ones, can significantly alter the binding of vitamin D metabolites to DBP.
    • The observed effects of FFAs on DBP binding suggest a potential mechanism for modulating vitamin D metabolite bioavailability in vivo.
    • Further research is warranted to elucidate the clinical implications of FFA-mediated alterations in vitamin D transport.